Your browser doesn't support javascript.
loading
A Synthetic Peptide Designed to Neutralize Lipopolysaccharides Attenuates Metaflammation and Diet-Induced Metabolic Derangements in Mice.
Mohammad, Shireen; Al Zoubi, Sura; Collotta, Debora; Krieg, Nadine; Wissuwa, Bianka; Ferreira Alves, Gustavo; Purvis, Gareth S D; Norata, Giuseppe Danilo; Baragetti, Andrea; Catapano, Alberico Luigi; Solito, Egle; Zechendorf, Elisabeth; Schürholz, Tobias; Correa-Vargas, Wilmar; Brandenburg, Klaus; Coldewey, Sina M; Collino, Massimo; Yaqoob, Muhammad M; Martin, Lukas; Thiemermann, Christoph.
Afiliación
  • Mohammad S; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Al Zoubi S; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Collotta D; Department of Basic Medical Sciences, School of Medicine, Al-Balqa Applied University, As-Salt, Jordan.
  • Krieg N; Department of Drug Science and Technology, University of Turin, Turin, Italy.
  • Wissuwa B; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
  • Ferreira Alves G; Septomics Research Center, Jena University Hospital, Jena, Germany.
  • Purvis GSD; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
  • Norata GD; Septomics Research Center, Jena University Hospital, Jena, Germany.
  • Baragetti A; Department of Drug Science and Technology, University of Turin, Turin, Italy.
  • Catapano AL; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Solito E; Sir William Dunn School Pathology, University of Oxford, Oxford, United Kingdom.
  • Zechendorf E; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
  • Schürholz T; IRCCS Multimedica, Sesto San Giovanni, Milan, Italy.
  • Correa-Vargas W; Società Italiana per lo Studio della Aterosclerosi (S.I.S.A.) Centre for the Study of Atherosclerosis, Bassini Hospital, Milan, Italy.
  • Brandenburg K; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
  • Coldewey SM; IRCCS Multimedica, Sesto San Giovanni, Milan, Italy.
  • Collino M; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
  • Yaqoob MM; IRCCS Multimedica, Sesto San Giovanni, Milan, Italy.
  • Martin L; Società Italiana per lo Studio della Aterosclerosi (S.I.S.A.) Centre for the Study of Atherosclerosis, Bassini Hospital, Milan, Italy.
  • Thiemermann C; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Front Immunol ; 12: 701275, 2021.
Article en En | MEDLINE | ID: mdl-34349763
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Lipopolisacáridos / Péptidos Catiónicos Antimicrobianos / Diabetes Mellitus Tipo 2 / Péptidos Antimicrobianos / Inflamación Tipo de estudio: Etiology_studies / Prognostic_studies Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Lipopolisacáridos / Péptidos Catiónicos Antimicrobianos / Diabetes Mellitus Tipo 2 / Péptidos Antimicrobianos / Inflamación Tipo de estudio: Etiology_studies / Prognostic_studies Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article